Tonghua Dongbao Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Tonghua Dongbao Pharmaceutical has a total shareholder equity of CN¥6.4B and total debt of CN¥492.7M, which brings its debt-to-equity ratio to 7.7%. Its total assets and total liabilities are CN¥7.1B and CN¥693.9M respectively. Tonghua Dongbao Pharmaceutical's EBIT is CN¥558.2M making its interest coverage ratio -4.8. It has cash and short-term investments of CN¥372.8M.
Key information
7.7%
Debt to equity ratio
CN¥492.75m
Debt
Interest coverage ratio | -4.8x |
Cash | CN¥372.83m |
Equity | CN¥6.43b |
Total liabilities | CN¥693.87m |
Total assets | CN¥7.12b |
Recent financial health updates
Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Pretty Healthy Balance Sheet
Oct 22Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Rock Solid Balance Sheet
Jun 19Recent updates
Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Pretty Healthy Balance Sheet
Oct 22Tonghua Dongbao Pharmaceutical Co., Ltd.'s (SHSE:600867) Earnings Haven't Escaped The Attention Of Investors
Sep 30Some May Be Optimistic About Tonghua Dongbao Pharmaceutical's (SHSE:600867) Earnings
Sep 06Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Analysts Just Slashed This Year's Estimates
Sep 05Calculating The Intrinsic Value Of Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867)
Aug 22Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Rock Solid Balance Sheet
Jun 19Improved Earnings Required Before Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Shares Find Their Feet
May 23Financial Position Analysis
Short Term Liabilities: 600867's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥455.8M).
Long Term Liabilities: 600867's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥238.1M).
Debt to Equity History and Analysis
Debt Level: 600867's net debt to equity ratio (1.9%) is considered satisfactory.
Reducing Debt: 600867's debt to equity ratio has increased from 2.5% to 7.7% over the past 5 years.
Debt Coverage: 600867's debt is well covered by operating cash flow (124.5%).
Interest Coverage: 600867 earns more interest than it pays, so coverage of interest payments is not a concern.